Zhongnan Medical Journal Press

Home Results

A total of 1203 result was found. Results

Alirocumab in the treatment of hypercholesterolemia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2023,32(12):1388-1400.
1220 times 481 times

Jian-Cheng ZHOU Chun-Mei JI Wen-Tong FANG Ying ZOU Yong-Qing WANG Yuan-Yuan FU

Alirocumab Hypercholesterolemia Safety Efficacy Cost-effectiveness Rapid health technology assessment
Details
Analysis of anticoagulant therapy and pharmaceutical care for a patient with obstetrical antiphospholipid syndrome complicated with HELLP syndrome

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):218-223.
1700 times 1459 times

ZHU Yue HUANG Xiaona

Obstetric antiphospholipid syndrome HELLP syndrome Anticoagulant therapy Pregnancy Lactation Pharmaceutical care
Details
Data mining for hypertension associated with VEGFR-TKIs: based on FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1201-1208.
1664 times 533 times

Xiao-Lan LIAO Jia-Qi GE Hai-Bin ZHU Ting-Ting WU Chun-Xia REN Zi-Cheng YU

Vascular endothelial growth factor receptor-tyrosine kinase inhibitors Hypertension Adverse drug events Pharmacovigilance FAERS database
Details
Poly ADP-ribose polymerase inhibitor-induced thrombocytopenia: recent advances in pathogenesis and treatments

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1209-1216.
1388 times 495 times

Ying-Chen ZHUO Su-Ya ZHANG Peng-Fei SONG Wei-Yi FENG

Poly ADP-ribose polymerase inhibitor Thrombocytopenia Ovarian cancer Adverse drug reaction
Details
Practice and reflection of pharmacovigilance system construction

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1217-1224.
1731 times 638 times

Na WANG Kang-Huai ZHANG

Pharmacovigilance Drug use safety Risk prevention and control Adverse drug reaction Medication error
Details
Clinical practice of drug abnormal early warning based on dynamic monitoring of clinical pharmacists

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1225-1230.
1741 times 593 times

Ting-Ting ZHENG Jin LI Lu MAO Ning CHEN Wei ZHANG Jian-Cun ZHEN

Rational drug use Abnormal early warning Dynamic monitoring Clinical pharmacist
Details
Clinical practice guidelines for the use of intravenous polymyxins in children: a protocol

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1231-1237.
1205 times 500 times

Lin TANG Shan SHEN Dong-Na ZOU Bing LENG Rui-Fang NIE Yan JIN Li-Kai LIN Xian-Tao ZENG Suo-Di ZHAI Ling-Li ZHANG Ning HOU

Polymyxins Pediatric medication Anti-infection Guideline protocol
Details
A retrospective study on the safety of off-indication use of pyrotinib in patients with non-small cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1238-1242.
1526 times 550 times

Hao-Chun TANG Jun MENG Zheng-Zheng XIA Ling-Zhi REN

Non-small cell lung cancer Pyrotinib Adverse drug reaction Safety Off-indication
Details
A retrospective study of potential drug-drug interactions of dabigatran etexilate in a tertiary hospital

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1243-1249.
1311 times 455 times

An-Hua WEI Wen-Jing LI Yan HUANG

Dabigatran etexilate Potential drug-drug interactions Safety Retrospective study
Details
Cost-effectiveness analysis of abemaciclib plus fulvestrant in the second-line treatment for HR﹢/HER2﹣ advanced breast cancer

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1259-1266.
1468 times 529 times

Xi ZHAO Xi YAN Ning LI Chun-Xia HOU

Abemaciclib Fulvestrant Hormone receptor-positive breast cancer Markov model Cost-effectiveness analysis
Details
Optimization of extraction process of Coptidis Rhizoma-Scutellariae Radix based on BP-ANN and CCD-RSM in information entropy theory

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1267-1274.
1340 times 448 times

Bao-Cai WANG Jun-Jiang LI Zhi-Wei XU

Coptidis Rhizoma-Scutellariae Radix BP-ANN CCD-RSM Extraction process Information entropy theory
Details
Treatment strategy selection for T2DM patients poorly treated with basal insulin combined with oral hypoglycemic agents: umbrella review

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1275-1284.
1409 times 492 times

Ya-Ping NIU San-Bao CHAI Jing-Zi MA Meng ZHANG Zuo-Xiang LIU Shan-Shan WU Feng SUN

Basal insulin Oral hypoglycemic agents Type 2 diabetes mellitus Poor treatment effect Umbrella review
Details
Analysis of clinical features of tacrolimus induced acute pancreatitis based on literature cases

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1285-1295.
1310 times 987 times

Chao YE Xin LI Li-Hua LIU Xin HE Shen-Jue CHEN Juan WANG

Tacrolimus Acute pancreatitis Case report Adverse drug reactions Literature analysis
Details
National competent authority regulation and practice of drug benefit-risk communication in the United States, European Union and China

Published on Chinese Journal of Pharmacoepidemiology 2024,33(1):19-27.
1181 times 919 times

ZHANG Yinan WU Tingxi ZHAO Zhigang

Drug benefit-risk communication Safety communication Drug safety information Pharmacovigilance
Details
A case of severe immune-related ulcerative colitis caused by pembrolizumab

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1311-1315.
1472 times 477 times

Jin-Jin ZOU Ji-Liang ZHANG Ni LI Ding-Yi LIU

Pembrolizumab Lung squamous cell carcinoma Severe immune-related ulcerative colitis Adverse drug reactions
Details